Latest News

Keep up to date with the latest news from Pilatus Biosciences.

News

April 2025

Pilatus Biosciences to Present Research on PLT012 at AACR 2025

November 2024

Pilatus Biosciences to Unveil Breakthrough Preclinical Data at SITC 2024: PLT012’s Transformative Potential in Liver Metastasis Treatment

November 2024

Pilatus Biosciences Inc. Receives Orphan Drug Designation from FDA for PLT012 in Treatment of Liver and Intrahepatic Bile Duct Cancer

October 2024

Pilatus Biosciences Announces Preclinical Data of Anti-PD-L1/IL-10 Immunocytokine PLT011 at SITC 2023

Upcoming Events

November 19, 2025

-

November 20, 2025

Boston

Shonan Health Innovation Conference

More Info

December 2, 2025

-

Paris

Health Horizon Conference

More Info